New In Situ Gel Eye Formulation Based on Aristoflex and Xanthan Gum in the Management of Glaucoma Disease: Nonclinical Studies | Synapse
March 16, 2026
New In Situ Gel Eye Formulation Based on Aristoflex and Xanthan Gum in the Management of Glaucoma Disease: Nonclinical Studies
Key Points
The research aims to evaluate the effectiveness of a gel formulation using Aristoflex and Xanthan Gum for glaucoma management.
Examined the formulation of in situ gels with Aristoflex and Xanthan Gum.
Assessed the retention time and effects on ocular health.
The combination of Aristoflex and Xanthan Gum showed high retention time in the ocular environment.
The formulation demonstrated reduced harmful effects for eye health.
Abstract
Therefore, the research provided a brief explanation that the combination of AF and XG can be utilized in in situ gels owing to its high retention time and reduced harmful effects for ocular illnesses.